^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Thyroid Gland Follicular Carcinoma |
| Drug: | Cabometyx (cabozantinib tablet) (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/05/2022
Excerpt:
Thyroid carcinoma - Papillary Carcinoma...Useful in Certain Circumstances...Cabozantinib (category 1) if progression after lenvatinib and/or sorafenib
